The evidence for sermorelin is stronger than for most longevity peptides
A1C and glucose help assess glycemic response, especially in people with diabetes
For many people it's B12 depletion and dehydration
In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after facing shortages since 2022 due to the drugs' growing popularity
(1) Both these findings on chronic and acute action of AOD 9604 suggested that while enhanced beta(3)-AR expression may have played a role in the chronic action of the compound, beta(3)-AR might not be the sole arbiter in this reaction
So, what is Liposomal Glutathione